PDT Partners’s Immunic IMUX Stock Holding History

PDT Partners’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-42	Closed	-$352K	–	1407
2015 Q2	$352K	Buy	+42	New	+$401K	0.01%	1085

Other funds holding IMUX

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PDT Partners's IMUX Position: Q3 2015 in Review

PDT Partners sold out of Immunic (IMUX) in Q3 2015, closing a stake of 42 shares — an estimated $352K sold.

PDT Partners first reported a position in IMUX in Q2 2015 and held it in 1 quarter. The position peaked at $352K in Q2 2015. 56 funds tracked by Wall St. Rank hold IMUX as of Q3 2015.

PDT Partners reported no remaining Immunic position as of Q3 2015 after selling out during the quarter.
PDT Partners sold 42 Immunic shares in Q3 2015, an estimated $352K.
PDT Partners first reported a position in Immunic in Q2 2015 and held it in 1 quarter.
PDT Partners's Immunic position peaked at $352K in Q2 2015.
56 funds tracked by Wall St. Rank held Immunic as of Q3 2015.

Based on PDT Partners's 13F filing for Q3 2015, filed 16 Nov 2015.